Valuation: HOB Biotech Group Corp.,Ltd

Market Cap 517.66Cr 76Cr 67Cr 62Cr 57Cr 107.48Cr 7.37TCr 109.2Cr 740.59Cr 290.31Cr 3.61TCr 287.05Cr 280.79Cr 12TCr P/E 2024
165x
P/E 2025 416x
Enterprise Value 516.07Cr 76Cr 67Cr 62Cr 57Cr 107.15Cr 7.35TCr 108.87Cr 738.3Cr 289.42Cr 3.6TCr 286.17Cr 279.93Cr 12TCr EV / Sales 2024
14.8x
EV / Sales 2025 24.2x
Free-Float
23.97%
Yield 2024
0.31%
Yield 2025 0.13%
1 day+1.32%
1 week-9.80%
Current month-14.65%
1 month-21.68%
3 months-39.77%
6 months-44.54%
Current year-46.30%
1 week 80
Extreme 80
99.85
1 month 80
Extreme 80
108.41
Current year 80
Extreme 80
166.01
1 year 80
Extreme 80
217
3 years 17.93
Extreme 17.93
217
5 years 17.93
Extreme 17.93
217
10 years 17.93
Extreme 17.93
217
Manager TitleAgeSince
Chief Executive Officer 63 19/07/2017
Director of Finance/CFO 58 16/04/2025
Investor Relations Contact 44 30/01/2022
Director TitleAgeSince
Chairman 63 19/07/2017
Director/Board Member 44 07/05/2025
Director/Board Member 44 07/07/2023
Date Insider Type Main position Quantity % Market Cap.
06/07/26 Sell

Chief Technology Officer

-13,000 0.1013%
27/11/25 Sell 200 0.0016%
14/07/25 Sell 200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+1.32%-9.80%-36.59%+139.46% 76Cr
-5.00%-6.52%+218.70%+296.86% 1.96TCr
-3.39%-0.85%-41.22%-27.21% 971.62Cr
-2.96%-0.94%+48.76%+22.92% 679.71Cr
-1.19%+3.47%+255.72%-26.12% 548.7Cr
+3.43%+5.63%-14.36%-20.49% 541.98Cr
-8.46%+30.96%+84.85%+109.54% 449.04Cr
-5.64%-8.79%-48.46% - 439.85Cr
-2.31%-1.58%-22.94%-26.56% 424.49Cr
+1.21%+4.55%-14.81%-38.52% 275.27Cr
Average -2.32%+0.81%+42.97%+47.76% 637.05Cr
Weighted average by Cap. -3.29%-0.12%+87.15%+98.56%

Financials

2024 2025
Net sales 40Cr 5.94Cr 5.21Cr 4.81Cr 4.43Cr 8.35Cr 572.95Cr 8.49Cr 58Cr 23Cr 280.34Cr 22Cr 22Cr 965.85Cr 40Cr 5.88Cr 5.16Cr 4.77Cr 4.38Cr 8.27Cr 567.34Cr 8.4Cr 57Cr 22Cr 277.59Cr 22Cr 22Cr 956.39Cr
Net income 3.68Cr 54.35L 47.64L 44.03L 40.5L 76.41L 52Cr 77.64L 5.27Cr 2.06Cr 26Cr 2.04Cr 2Cr 88Cr 2.32Cr 34.26L 30.03L 27.76L 25.53L 48.17L 33Cr 48.94L 3.32Cr 1.3Cr 16Cr 1.29Cr 1.26Cr 56Cr
Net Debt -59.32L -9L -8L -7L -7L -12.32L -8.45Cr -12.51L -84.87L -33.27L -4.13Cr -32.9L -32.18L -14Cr -1.59Cr -23.55L -20.64L -19.08L -17.55L -33.11L -23Cr -33.64L -2.28Cr -89.44L -11Cr -88.44L -86.51L -38Cr
Logo HOB Biotech Group Corp.,Ltd
HOB Biotech Group Corp Ltd is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic reagents. The Company's products are mainly used for the detection of allergic and autoimmune diseases, and the test reagents it produces are used for the clinical auxiliary diagnosis of allergic and autoimmune diseases. The detection techniques include qualitative detection techniques such as enzyme-linked immunosorbent assay, and quantitative detection techniques such as enzyme-linked immunoassay capture method and nano-magnetic particle chemiluminescence method. The brands of allergy testing products include Oboke, Fubok, Shibok and Shibok Plus. The self-immune testing product brands include Norbok and Nabok. It is also engaged in the provision of reagent supporting testing instruments and others.
Employees
546
Date Price Change Volume
20/26/20 CN¥82.59 +1.32% 9,40,106
17/26/17 CN¥81.51 -14.24% 10,75,009
16/26/16 CN¥95.04 -0.56% 8,39,230
15/26/15 CN¥95.58 +3.34% 8,41,464
14/26/14 CN¥92.49 +1.02% 6,40,256
  1. Stock Market
  2. Stocks
  3. 688656 Stock